相关实验视频

Updated: May 27, 2025

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

二复合物作为癌症治疗的新型候选者

Oscar A Lenis-Rojas¹, Catarina Roma-Rodrigues², Beatriz Carvalho²

¹Instituto de Tecnologia Química e Biológica António Xavier, ITQB NOVA, Av. da República, 2780-157, Oeiras, Portugal.

|February 15, 2025

概括

新的 (Ru) 复合物显示出作为抗癌剂的前景. 这些化合物有效地向并减少瘤细胞的增殖,其中一种变体在斑马鱼模型中显示出对癌细胞的高选择性和对健康细胞的最小毒性.

科学领域:

有机金属化学有机金属化学
药用化学医学化学
癌症研究癌症研究

背景情况:

鲁 (Ru) 复合物因其治疗潜力而受到探索.
三聚烯-三化物联体为金属复合体提供独特的协调特性.

研究的目的:

为了合成和表征新的Ru(II) η⁶-arene复合物与双酸三利烯-三酸连接体.
评估这些复合物的抗增殖活性和选择性,与各种癌症细胞系和体内模型对比.

主要方法:

合成和Ru(II) η⁶-arene复合物的完整表征.
针对卵巢和结直肠癌细胞系 (包括耐药变体) 和人类皮肤纤维细胞的体外抗增殖试验.
使用斑马鱼模型进行体内研究,以评估抗癌疗效和毒性.

主要成果:

两种合成的Ru复合体都显示出抗增殖作用.
p-cymene Ru复合物显示出更强的整体抗增殖活性,而复合物则表现出更高的瘤细胞选择性.
复合物诱导了细胞亡,抑制了细胞迁移和血管生成,并且在斑马鱼中显示出显著的癌细胞向与低毒性.

结论:

新型Ru(II) 三聚烯-三化物复合物具有显著的抗癌性质.
这项研究为斑马鱼模型中Ru triazolylidenes的抗癌潜力提供了第一个体内证据.
这些发现强调了这些Ru复合物的治疗承诺,用于癌症治疗.

关键词:

在CAM测试中使用CAM测试.这是一种抗癌药物.鲁是的元素之一.三醇化物中的三醇化物斑马鱼的异种移植

更多相关视频

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...